BC
Blackcrane Capital Portfolio holdings
AUM
$16.3M
This Quarter Return
+4.13%
1 Year Return
-19.53%
3 Year Return
+33.91%
5 Year Return
–
10 Year Return
–
AUM
$42.9M
AUM Growth
+$42.9M
(-52%)
Cap. Flow
-$48.2M
Cap. Flow
% of AUM
-112.44%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
1
Reduced
6
Closed
1
Top Buys
| 1 |
PROF
Profound Medical
PROF
|
$381K |
Top Sells
| 1 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$15.5M |
| 2 |
Avita Medical
RCEL
|
$11.2M |
| 3 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$5.7M |
| 4 |
WIX.com
WIX
|
$5.29M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$5.12M |
Sector Composition
| 1 | Healthcare | 58.61% |
| 2 | Technology | 41.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Avita Medical
RCEL
$117M
| $12M | 27.88% |
474,982
-446,681
| -48% | -$11.2M |
|
|
2
WIX.com
WIX
$7.85B
| $10.6M | 24.74% |
41,610
-20,769
| -33% | -$5.29M |
|
|
AXNX
3
DELISTED
Axonics, Inc. Common Stock
AXNX
| $6.37M | 14.86% |
124,787
-303,572
| -71% | -$15.5M |
|
4
Nice
NICE
$8.73B
| $5.89M | 13.75% |
25,952
-17,705
| -41% | -$4.02M |
|
|
PROF
5
Profound Medical
PROF
$134M
| $3.47M | 8.11% |
196,924
+21,623
| +12% | +$381K |
|
|
BHVN
6
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.87M | 6.69% |
44,112
-78,753
| -64% | -$5.12M |
|
7
Microsoft
MSFT
$3.77T
| $1.24M | 2.9% |
5,904
-8,135
| -58% | -$1.71M |
|
8
Takeda Pharmaceutical
TAK
$47.3B
| $459K | 1.07% |
25,723
| – | – |
|
|
IMDX
9
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| – | – |
-2,982,557
| Closed | -$5.7M |
|